• Health & Medicine

Removing cancer's protective barrier could boost immunotherapy treatments

Scientists may have found a way to pull down the protective wall that surrounds tumours, potentially re-exposing them to the killing power of the immune system. Scientists may have found a way to pull down the protective wall that surrounds tumours, potentially re-exposing them to the killing power of the immune system.

26 August 2019

• Health & Medicine

Lung cancer immunotherapy combo added to Cancer Drugs Fund

Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England. Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.

8 August 2019

• Health & Medicine

New skin cancer immunotherapy added to NHS England’s Cancer Drugs Fund

A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England. A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England.

4 July 2019

• Science & Technology
• Health & Medicine

News digest – obesity projections, immunotherapy trials, Vitamin D and cancer ‘cure’ documentaries

In the news this week: The low-down from the world’s largest cancer conference and the dangerous documentaries spreading misinformation about cancer. In the news this week: The low-down from the world’s largest cancer conference and the dangerous documentaries spreading misinformation about cancer.

8 June 2019

• Health & Medicine

Immunotherapy comparable to chemo for some advanced stomach cancers

An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe. An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.

1 June 2019

• Health & Medicine

Kidney cancer immunotherapy combo approved for NHS use in England

A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England. A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.

5 April 2019

• Science & Technology
• Health & Medicine

News digest – discount junk food deals, lung cancer immunotherapy, cigarettes and wine

In this week’s news: new research asks, ‘how many cigarettes are in a bottle of wine?’ and special offers fuel obese shoppers. In this week’s news: new research asks, ‘how many cigarettes are in a bottle of wine?’ and special offers fuel obese shoppers.

30 March 2019

• Health & Medicine

Lung cancer immunotherapy approved for NHS patients in England

An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer. An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer.

28 March 2019

• Health & Medicine

Cancer Research UK, LifeArc and Ono Pharma form cancer immunotherapy alliance

New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance announced today. New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance announced today.

27 March 2019

• Health & Medicine

CAR T cell immunotherapy for lymphoma rejected in Scotland

Patients living with an aggressive form of lymphoma in Scotland will not get access to a new immunotherapy treatment after it was rejected for use on the NHS. Patients living with an aggressive form of lymphoma in Scotland will not get access to a new immunotherapy treatment after it was rejected for use on the NHS.

13 March 2019

• Health & Medicine

Double NHS decision for CAR T cell immunotherapy in Scotland

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer. Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

13 February 2019

• Health & Medicine

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England. People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

13 December 2018